Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunodeficiency in epilepsy: a new view

A Fontana, P J Grob

    Journal of Neurology
    |January 5, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Epilepsy patients often have low immunoglobulin A (IgA) levels, which can be a consistent finding. Changes in hydantoin medication may affect these IgA levels in individuals with epilepsy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Abstracts of the 6th FECS Conference 1998 Lectures.

    Environmental science and pollution research international·2008
    Same author

    Temporally controlled modulation of antihydrogen production and the temperature scaling of antiproton-positron recombination.

    Physical review letters·2008
    Same author

    Neutron scattering study of the vibrations in vitreous silica and germania.

    The Journal of chemical physics·2008
    Same author

    Damping of sound waves in the terahertz range and strength of the boson peak.

    The Journal of chemical physics·2008
    Same author

    Phase II study of sequential chemotherapy with docetaxel-estramustine followed by mitoxantrone-prednisone in patients with advanced hormone-refractory prostate cancer.

    British journal of cancer·2007
    Same author

    [Early infantile and late infantile form of Krabbe disease: CT and MRI findings].

    La Pediatria medica e chirurgica : Medical and surgical pediatrics·2007
    Same journal

    The dual role of mTOR in multiple sclerosis pathophysiology: a systematic review.

    Journal of neurology·2026
    Same journal

    Brain-first versus body-first Parkinson's disease: Differential findings on pupillary, brainstem and vagus sonography.

    Journal of neurology·2026
    Same journal

    Spontaneous intracranial hypotension due to pelvic cerebrospinal fluid leak.

    Journal of neurology·2026
    Same journal

    Morbidity and medication use preceding a diagnosis of late-onset Alzheimer's disease: a Danish nationwide study.

    Journal of neurology·2026
    Same journal

    Comorbid autoimmune disease in stiff-person syndrome spectrum disorder: a systematic review and meta-analysis.

    Journal of neurology·2026
    Same journal

    Tetrahydrocannabinol/cannabidiol in the treatment of restless legs syndrome.

    Journal of neurology·2026
    See all related articles

    Area of Science:

    • Neurology
    • Immunology
    • Clinical Pharmacology

    Background:

    • Subnormal immunoglobulin A (IgA) serum concentrations are observed in up to 12% of patients with epilepsy.
    • Previous research suggests a correlation between IgA deficiency, hydantoin treatment, and seizure types.

    Purpose of the Study:

    • To investigate the constancy of IgA deficiency in epileptic patients.
    • To examine the relationship between changes in hydantoin medication and IgA levels.
    • To introduce a new classification for immunodeficiency in epilepsy.

    Main Methods:

    • Follow-up study design.
    • Monitoring of serum IgA concentrations in epileptic patients.
    • Correlation analysis with hydantoin treatment and seizure types.

    Related Experiment Videos

    Main Results:

    • IgA deficiency in epileptic patients is generally a stable characteristic of the individual.
    • Significant alterations in IgA levels were noted in patients whose hydantoin medication was modified.
    • Low IgA levels were also reported in untreated epileptic individuals.

    Conclusions:

    • IgA deficiency is a persistent feature in many epilepsy patients.
    • Hydantoin medication adjustments can influence IgA levels.
    • A novel classification for immunodeficiency states in epilepsy is proposed.